BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21339088)

  • 21. Surgery on neuroendocrine tumours.
    Akerström G; Hellman P
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):87-109. PubMed ID: 17382267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
    Machado MC
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):145-8. PubMed ID: 22584720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple endocrine neoplasia type 1 presenting as insulinoma, gastrinoma, and postbulbar duodenal ulcers: report of a case.
    Murakami S; Satomi A; Ishida K; Matsuki M; Koda H; Miura S
    Surg Today; 1995; 25(9):848-51. PubMed ID: 8555708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1. I. Diagnosis].
    Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
    Dtsch Med Wochenschr; 2004 Mar; 129(12):630-3. PubMed ID: 15011133
    [No Abstract]   [Full Text] [Related]  

  • 26. [Various neuroendocrine tumors in a family with multiple endocrine neoplasia type 1].
    Sepp K; Valkusz Z
    Orv Hetil; 2013 Dec; 154(51):2037-42. PubMed ID: 24334135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
    Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
    Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
    Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
    Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic gastrinoma in MEN I syndrome.
    Bauer VP; Horovitz J
    J Am Coll Surg; 2003 Apr; 196(4):652-3. PubMed ID: 12691945
    [No Abstract]   [Full Text] [Related]  

  • 31. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The diagnosis and treatment of insulinoma and gastrinoma].
    Honda M; Ishibashi M
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):337-41. PubMed ID: 15045936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
    Arnold R; Neuhaus C; Trautmann ME
    Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas.
    Fendrich V; Langer P; Waldmann J; Bartsch DK; Rothmund M
    Br J Surg; 2007 Nov; 94(11):1331-41. PubMed ID: 17939142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare syndromes.
    Jabbour SA; Davidovici BB; Wolf R
    Clin Dermatol; 2006; 24(4):299-316. PubMed ID: 16828412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new concept of therapeutic strategy for neuroendocrine tumors: important information from a case report of gastrinoma.
    Igarashi H; Ito T; Takayanagi R
    Intern Med; 2010; 49(17):1839-40. PubMed ID: 20823641
    [No Abstract]   [Full Text] [Related]  

  • 38. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical aspects of MEN I syndrome.
    Budayar M; Duke BE
    Am Surg; 1996 Jun; 62(6):427-31. PubMed ID: 8651521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1). Implications for an integrated model of MEN-1 tumorigenesis.
    Burgess JR; Greenaway TM; Parameswaran V; Shepherd JJ
    Cancer; 1999 Nov; 86(10):2154-9. PubMed ID: 10570446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.